| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 7.85e-06 | 15 | 53 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 2.46e-04 | 9 | 53 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.36e-04 | 51 | 53 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.20e-04 | 55 | 53 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.43e-04 | 60 | 53 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.76e-04 | 562 | 53 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 7.10e-04 | 15 | 53 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.17e-03 | 78 | 53 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.23e-03 | 303 | 53 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 1.69e-03 | 23 | 53 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.52e-03 | 102 | 53 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.66e-03 | 104 | 53 | 3 | GO:0016407 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.12e-04 | 7 | 49 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.49e-04 | 8 | 49 | 2 | GO:0070775 | |
| HumanPheno | Laryngomalacia | 2.85e-06 | 84 | 15 | 5 | HP:0001601 | |
| HumanPheno | Abnormal larynx morphology | 1.30e-05 | 201 | 15 | 6 | HP:0025423 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 1.89e-05 | 474 | 15 | 8 | HP:0006493 | |
| HumanPheno | Abnormality of the larynx | 2.54e-05 | 666 | 15 | 9 | HP:0001600 | |
| HumanPheno | Aplasia involving bones of the extremities | 7.43e-05 | 759 | 15 | 9 | HP:0009825 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 7.59e-05 | 761 | 15 | 9 | HP:0045060 | |
| HumanPheno | Brachydactyly (hand) | 1.03e-04 | 430 | 15 | 7 | HP:0100667 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 1.22e-04 | 298 | 15 | 6 | HP:0006494 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 1.29e-04 | 813 | 15 | 9 | HP:0009815 | |
| HumanPheno | Abnormal columella morphology | 1.44e-04 | 97 | 15 | 4 | HP:0009929 | |
| HumanPheno | Brachydactyly | 2.36e-04 | 670 | 15 | 8 | HP:0001156 | |
| HumanPheno | Abnormality of the upper respiratory tract | IGF1R HDAC4 KAT6A SLC19A2 SMARCC2 RILPL1 GNAS KAT6B EP300 HNRNPR | 2.38e-04 | 1111 | 15 | 10 | HP:0002087 |
| HumanPheno | Short digit | 2.41e-04 | 672 | 15 | 8 | HP:0011927 | |
| HumanPheno | Abnormal nasal septum morphology | 2.78e-04 | 115 | 15 | 4 | HP:0000419 | |
| HumanPheno | Short toe | 2.87e-04 | 116 | 15 | 4 | HP:0001831 | |
| HumanPheno | Ventricular septal defect | 3.04e-04 | 510 | 15 | 7 | HP:0001629 | |
| HumanPheno | Short palm | 3.07e-04 | 118 | 15 | 4 | HP:0004279 | |
| HumanPheno | Abnormal ventricular septum morphology | 3.48e-04 | 521 | 15 | 7 | HP:0010438 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 4.25e-04 | 538 | 15 | 7 | HP:0005927 | |
| HumanPheno | Abnormality of dental eruption | 4.53e-04 | 240 | 15 | 5 | HP:0006292 | |
| HumanPheno | Low hanging columella | 5.22e-04 | 56 | 15 | 3 | HP:0009765 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 5.89e-04 | 140 | 15 | 4 | HP:0001991 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 6.22e-04 | 572 | 15 | 7 | HP:0006496 | |
| HumanPheno | Thin scalp hair | 6.39e-04 | 143 | 15 | 4 | HP:0002556 | |
| HumanPheno | Thin hair | 6.39e-04 | 143 | 15 | 4 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 6.39e-04 | 143 | 15 | 4 | HP:0002209 | |
| HumanPheno | Abnormal cardiac ventricle morphology | 6.88e-04 | 780 | 15 | 8 | HP:0001713 | |
| HumanPheno | Short metatarsal | 7.04e-04 | 62 | 15 | 3 | HP:0010743 | |
| HumanPheno | Functional abnormality of male internal genitalia | SLC26A8 HDAC4 KAT6A SLC19A2 SMARCC2 GNAS KAT6B CNGB1 EP300 HNRNPR | 7.57e-04 | 1269 | 15 | 10 | HP:0000025 |
| HumanPheno | Short 5th finger | 7.73e-04 | 64 | 15 | 3 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of metatarsal bones | 8.46e-04 | 66 | 15 | 3 | HP:0001964 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 8.46e-04 | 66 | 15 | 3 | HP:0006262 | |
| Domain | GAGE | XAGE3 GAGE4 GAGE5 XAGE2 GAGE13 GAGE12J GAGE12H GAGE2A GAGE1 GAGE12F GAGE12I | 9.65e-23 | 24 | 54 | 11 | PF05831 |
| Domain | GAGE_fam | XAGE3 GAGE4 GAGE5 XAGE2 GAGE13 GAGE12J GAGE12H GAGE2A GAGE1 GAGE12F GAGE12I | 1.72e-22 | 25 | 54 | 11 | IPR008625 |
| Domain | GAGE | 5.53e-14 | 19 | 54 | 7 | SM01379 | |
| Domain | GAGE | 5.53e-14 | 19 | 54 | 7 | IPR031320 | |
| Domain | MOZ_SAS | 8.16e-05 | 5 | 54 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 8.16e-05 | 5 | 54 | 2 | IPR002717 | |
| Domain | MYST_HAT | 8.16e-05 | 5 | 54 | 2 | PS51726 | |
| Domain | H15 | 6.27e-04 | 13 | 54 | 2 | SM00526 | |
| Domain | H15 | 6.27e-04 | 13 | 54 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 7.30e-04 | 14 | 54 | 2 | IPR005818 | |
| Domain | PHD | 1.33e-03 | 75 | 54 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 1.55e-03 | 79 | 54 | 3 | IPR019787 | |
| Domain | RRM_dom_euk | 2.00e-03 | 23 | 54 | 2 | IPR003954 | |
| Domain | GUANYLATE_KINASE_2 | 2.00e-03 | 23 | 54 | 2 | PS50052 | |
| Domain | RRM_1 | 2.00e-03 | 23 | 54 | 2 | SM00361 | |
| Domain | GUANYLATE_KINASE_1 | 2.00e-03 | 23 | 54 | 2 | PS00856 | |
| Domain | PHD | 2.18e-03 | 89 | 54 | 3 | SM00249 | |
| Domain | Znf_PHD | 2.32e-03 | 91 | 54 | 3 | IPR001965 | |
| Domain | Guanylate_kin | 2.55e-03 | 26 | 54 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 2.55e-03 | 26 | 54 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 2.55e-03 | 26 | 54 | 2 | IPR008144 | |
| Domain | GuKc | 2.55e-03 | 26 | 54 | 2 | SM00072 | |
| Domain | SANT_dom | 2.55e-03 | 26 | 54 | 2 | IPR017884 | |
| Domain | ZF_PHD_2 | 2.62e-03 | 95 | 54 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 2.70e-03 | 96 | 54 | 3 | PS01359 | |
| Domain | SANT | 2.96e-03 | 28 | 54 | 2 | PS51293 | |
| Domain | Myb_DNA-binding | 4.59e-03 | 35 | 54 | 2 | PF00249 | |
| Domain | MYB_LIKE | 5.40e-03 | 38 | 54 | 2 | PS50090 | |
| Domain | - | 5.97e-03 | 40 | 54 | 2 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 7.50e-03 | 45 | 54 | 2 | IPR016181 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 4.15e-05 | 26 | 37 | 3 | M2499 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.87e-05 | 272 | 37 | 6 | M29619 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 8.80e-05 | 175 | 37 | 5 | MM14941 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 9.99e-05 | 6 | 37 | 2 | M22062 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 9.99e-05 | 6 | 37 | 2 | MM15545 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 2.98e-04 | 10 | 37 | 2 | M27824 | |
| Pubmed | An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members. | GAGE4 GAGE5 GAGE7 GAGE2B GAGE13 GAGE12J GAGE12H GAGE1 GAGE12F GAGE12I | 1.61e-23 | 20 | 59 | 10 | 18179644 |
| Pubmed | 1.53e-15 | 9 | 59 | 6 | 7544395 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | GAGE5 GAGE7 GAGE2B GAGE13 GAGE12J GAGE12G GAGE1 GAGE12F GAGE12I | 5.14e-13 | 119 | 59 | 9 | 28625976 |
| Pubmed | 2.96e-12 | 10 | 59 | 5 | 9651357 | ||
| Pubmed | Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. | 5.41e-12 | 11 | 59 | 5 | 10397259 | |
| Pubmed | 9.36e-09 | 157 | 59 | 7 | 30186101 | ||
| Pubmed | XAGE3 GAGE7 XAGE2 GAGE2B GAGE13 GAGE12J GAGE12H GAGE2A GAGE12I | 2.83e-08 | 407 | 59 | 9 | 15772651 | |
| Pubmed | RCOR1 LIN37 HDAC4 TCERG1 PRRC2C ZFP91 SMARCC2 IKZF1 PSME2 DEK EP300 CDC23 HNRNPR | 3.20e-08 | 1103 | 59 | 13 | 34189442 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 17182677 | ||
| Pubmed | 2.54e-07 | 154 | 59 | 6 | 36490346 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PELP1 TCERG1 TJP1 PRRC2C RBM19 SMARCC2 NCL KIF18B DEK EPB41 HNRNPR | 5.25e-07 | 954 | 59 | 11 | 36373674 |
| Pubmed | Acetylation of HIV-1 integrase by p300 regulates viral integration. | 7.58e-07 | 11 | 59 | 3 | 16096645 | |
| Pubmed | 8.97e-07 | 191 | 59 | 6 | 20195357 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30871606 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27185879 | ||
| Pubmed | MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). | 2.83e-06 | 2 | 59 | 2 | 10824998 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 39505971 | ||
| Pubmed | Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1. | 2.83e-06 | 2 | 59 | 2 | 34936696 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24150941 | ||
| Pubmed | 2.99e-06 | 131 | 59 | 5 | 34551306 | ||
| Pubmed | NPTN RCOR1 HDAC4 PELP1 TJP1 PRRC2C SMARCC2 GOLGA8K NCL CCDC177 | 4.65e-06 | 963 | 59 | 10 | 28671696 | |
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 8.48e-06 | 3 | 59 | 2 | 36754959 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 33966634 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 23063713 | ||
| Pubmed | The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma. | 8.48e-06 | 3 | 59 | 2 | 25884514 | |
| Pubmed | 9.16e-06 | 615 | 59 | 8 | 31048545 | ||
| Pubmed | 1.16e-05 | 298 | 59 | 6 | 30737378 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.33e-05 | 178 | 59 | 5 | 27637333 | |
| Pubmed | RCOR1 ARHGEF40 P3H3 KAT6A ZFP91 SMARCC2 KIF18B KAT6B EP300 CDC23 | 1.67e-05 | 1116 | 59 | 10 | 31753913 | |
| Pubmed | ARHGEF40 UPF2 TCERG1 TJP1 PRRC2C RBM19 ZFP91 SMARCC2 NCL GNAS DEK | 1.68e-05 | 1371 | 59 | 11 | 36244648 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 23349832 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 17980166 | ||
| Pubmed | p300/CBP-associated factor drives DEK into interchromatin granule clusters. | 1.69e-05 | 4 | 59 | 2 | 15987677 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 21880731 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 30030465 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 11481323 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 10197611 | ||
| Pubmed | B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription. | 1.69e-05 | 4 | 59 | 2 | 31941781 | |
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 2.82e-05 | 5 | 59 | 2 | 11965546 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 26625199 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 19071119 | ||
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 15280364 | ||
| Pubmed | Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation. | 2.82e-05 | 5 | 59 | 2 | 16582966 | |
| Pubmed | Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription. | 2.82e-05 | 5 | 59 | 2 | 16922677 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 21282606 | ||
| Pubmed | Phosphorylation of p300 increases its protein degradation to enhance the lung cancer progression. | 2.82e-05 | 5 | 59 | 2 | 24530506 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.12e-05 | 759 | 59 | 8 | 35915203 | |
| Pubmed | Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. | 4.23e-05 | 6 | 59 | 2 | 10825153 | |
| Pubmed | MOZ is essential for maintenance of hematopoietic stem cells. | 4.23e-05 | 6 | 59 | 2 | 16702405 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 19001415 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 21148070 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 31863900 | ||
| Pubmed | Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma. | 4.23e-05 | 6 | 59 | 2 | 24229708 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 4.38e-05 | 40 | 59 | 3 | 34585037 | |
| Pubmed | 4.64e-05 | 116 | 59 | 4 | 21549307 | ||
| Pubmed | 4.99e-05 | 1014 | 59 | 9 | 32416067 | ||
| Pubmed | 5.08e-05 | 42 | 59 | 3 | 16387653 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 5.52e-05 | 394 | 59 | 6 | 27248496 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.86e-05 | 1294 | 59 | 10 | 30804502 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 16601680 | ||
| Pubmed | Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. | 5.91e-05 | 7 | 59 | 2 | 18794358 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 11992404 | ||
| Pubmed | 5.98e-05 | 1297 | 59 | 10 | 33545068 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 7.26e-05 | 605 | 59 | 7 | 28977666 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 24413532 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 19754958 | ||
| Pubmed | Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. | 7.87e-05 | 8 | 59 | 2 | 17158926 | |
| Pubmed | Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. | 7.87e-05 | 8 | 59 | 2 | 16696975 | |
| Pubmed | Differential expression of HDAC and HAT genes in atrophying skeletal muscle. | 7.87e-05 | 8 | 59 | 2 | 26372908 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 19281832 | ||
| Pubmed | 8.86e-05 | 847 | 59 | 8 | 35850772 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 16613856 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 11058868 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 1.23e-04 | 1415 | 59 | 10 | 28515276 | |
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 11546874 | ||
| Pubmed | Esco2 is a novel corepressor that associates with various chromatin modifying enzymes. | 1.26e-04 | 10 | 59 | 2 | 18501190 | |
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 15138260 | ||
| Pubmed | 1.27e-04 | 57 | 59 | 3 | 21122108 | ||
| Pubmed | 1.27e-04 | 57 | 59 | 3 | 38223760 | ||
| Pubmed | 1.27e-04 | 57 | 59 | 3 | 18022353 | ||
| Pubmed | 1.54e-04 | 11 | 59 | 2 | 22479204 | ||
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 1.65e-04 | 161 | 59 | 4 | 32572027 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.69e-04 | 162 | 59 | 4 | 31363146 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.74e-04 | 486 | 59 | 6 | 30940648 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.80e-04 | 701 | 59 | 7 | 30196744 | |
| Pubmed | 1.88e-04 | 65 | 59 | 3 | 22379092 | ||
| Pubmed | Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. | 2.18e-04 | 13 | 59 | 2 | 17765891 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.19e-04 | 724 | 59 | 7 | 36232890 | |
| Pubmed | 2.38e-04 | 1247 | 59 | 9 | 27684187 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.53e-04 | 1257 | 59 | 9 | 36526897 | |
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 2.54e-04 | 14 | 59 | 2 | 12015313 | |
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 15601857 | ||
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 27593939 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.55e-04 | 989 | 59 | 8 | 36424410 | |
| Pubmed | 2.82e-04 | 340 | 59 | 5 | 24332808 | ||
| Pubmed | 2.86e-04 | 186 | 59 | 4 | 14744259 | ||
| Pubmed | 2.87e-04 | 75 | 59 | 3 | 25593309 | ||
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 31552487 | ||
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 15674325 | ||
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 28784777 | ||
| Interaction | GMCL1 interactions | 1.17e-08 | 154 | 57 | 8 | int:GMCL1 | |
| Interaction | FLT3 interactions | GAGE5 GAGE7 GAGE2B GAGE13 GAGE12J GAGE12G GAGE1 GAGE12F GAGE12I | 2.51e-07 | 318 | 57 | 9 | int:FLT3 |
| Interaction | GMCL2 interactions | 3.17e-06 | 36 | 57 | 4 | int:GMCL2 | |
| Interaction | H3-4 interactions | 4.27e-06 | 448 | 57 | 9 | int:H3-4 | |
| Interaction | CHD3 interactions | RCOR1 LIN37 PELP1 TCERG1 PRRC2C KAT6A SMARCC2 IKZF1 NCL EP300 HNRNPR | 7.43e-06 | 757 | 57 | 11 | int:CHD3 |
| Interaction | CHD4 interactions | RCOR1 LIN37 TCF19 PRRC2C RBM19 KAT6A SMARCC2 IKZF1 NCL DEK EP300 HNRNPR | 9.81e-06 | 938 | 57 | 12 | int:CHD4 |
| Interaction | SMC5 interactions | HDAC4 PELP1 TCERG1 TJP1 PRRC2C RBM19 SMARCC2 NCL KIF18B DEK EPB41 HNRNPR | 1.86e-05 | 1000 | 57 | 12 | int:SMC5 |
| Interaction | H2BC21 interactions | RCOR1 PELP1 KAT6A SMARCC2 ARHGAP30 NCL KIF18B KAT6B DEK EP300 | 2.25e-05 | 696 | 57 | 10 | int:H2BC21 |
| Interaction | HDAC2 interactions | RCOR1 LIN37 PELP1 PRRC2C SMARCC2 IKZF1 NCL DEK EP300 CDC23 HNRNPR | 2.58e-05 | 865 | 57 | 11 | int:HDAC2 |
| Interaction | CHAF1A interactions | 3.32e-05 | 322 | 57 | 7 | int:CHAF1A | |
| Interaction | CEBPA interactions | RCOR1 LIN37 HDAC4 TCERG1 PRRC2C ZFP91 SMARCC2 IKZF1 PSME2 DEK EP300 CDC23 HNRNPR | 3.42e-05 | 1245 | 57 | 13 | int:CEBPA |
| Interaction | RUNX1 interactions | 3.45e-05 | 324 | 57 | 7 | int:RUNX1 | |
| Interaction | H3C1 interactions | RCOR1 PELP1 PRRC2C KAT6A ZFP91 SMARCC2 KIF18B KAT6B DEK EP300 CDC23 | 3.75e-05 | 901 | 57 | 11 | int:H3C1 |
| Interaction | SMARCA4 interactions | 4.43e-05 | 462 | 57 | 8 | int:SMARCA4 | |
| Interaction | LUC7L interactions | 6.13e-05 | 242 | 57 | 6 | int:LUC7L | |
| Interaction | ING4 interactions | 7.02e-05 | 78 | 57 | 4 | int:ING4 | |
| Interaction | FBL interactions | 7.07e-05 | 639 | 57 | 9 | int:FBL | |
| Interaction | MTA3 interactions | 1.28e-04 | 173 | 57 | 5 | int:MTA3 | |
| Interaction | MGMT interactions | 1.34e-04 | 92 | 57 | 4 | int:MGMT | |
| Interaction | MTA1 interactions | 1.45e-04 | 283 | 57 | 6 | int:MTA1 | |
| Interaction | SMARCA5 interactions | 1.62e-04 | 415 | 57 | 7 | int:SMARCA5 | |
| Interaction | RNPS1 interactions | 1.88e-04 | 425 | 57 | 7 | int:RNPS1 | |
| Interaction | FOXP3 interactions | 2.08e-04 | 432 | 57 | 7 | int:FOXP3 | |
| Interaction | TBL1XR1 interactions | 2.09e-04 | 192 | 57 | 5 | int:TBL1XR1 | |
| Interaction | YAP1 interactions | IGF1R TCERG1 TJP1 PRRC2C SMARCC2 NCL GNAS EP300 EPB41 CDC23 HNRNPR | 2.13e-04 | 1095 | 57 | 11 | int:YAP1 |
| Interaction | MTA2 interactions | 2.17e-04 | 435 | 57 | 7 | int:MTA2 | |
| Interaction | SUMO2 interactions | 2.43e-04 | 591 | 57 | 8 | int:SUMO2 | |
| Interaction | NFATC2 interactions | 2.52e-04 | 200 | 57 | 5 | int:NFATC2 | |
| Interaction | PRPF40A interactions | 2.52e-04 | 446 | 57 | 7 | int:PRPF40A | |
| Interaction | C16orf87 interactions | 2.62e-04 | 44 | 57 | 3 | int:C16orf87 | |
| Interaction | USP24 interactions | 2.85e-04 | 112 | 57 | 4 | int:USP24 | |
| Interaction | RBM25 interactions | 2.95e-04 | 323 | 57 | 6 | int:RBM25 | |
| Interaction | DEK interactions | 3.09e-04 | 209 | 57 | 5 | int:DEK | |
| Cytoband | Xp11.23 | GAGE2B GAGE13 GAGE12J GAGE12G GAGE12H GAGE2A GAGE1 GAGE12F GAGE12I | 5.44e-15 | 95 | 59 | 9 | Xp11.23 |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | XAGE3 XAGE2 GAGE13 GAGE12J GAGE12G GAGE12H GAGE2A GAGE1 GAGE12F | 1.35e-09 | 377 | 59 | 9 | chrXp11 |
| Cytoband | Xp11.4-p11.2 | 4.02e-08 | 6 | 59 | 3 | Xp11.4-p11.2 | |
| Cytoband | 1q23.3 | 3.56e-05 | 49 | 59 | 3 | 1q23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 2.98e-04 | 100 | 59 | 3 | chr15q13 | |
| Cytoband | Xp11.22 | 2.23e-03 | 54 | 59 | 2 | Xp11.22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q21 | 4.69e-03 | 79 | 59 | 2 | chr16q21 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.70e-06 | 17 | 33 | 3 | 486 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 3.82e-04 | 16 | 33 | 2 | 66 | |
| GeneFamily | PHD finger proteins | 5.84e-04 | 90 | 33 | 3 | 88 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.02e-03 | 26 | 33 | 2 | 904 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.20e-03 | 53 | 33 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 6.78e-03 | 213 | 33 | 3 | 725 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | RCOR1 PELP1 UPF2 TCERG1 PRRC2C IKZF1 NCL PSME2 DEK EP300 EPB41 HNRNPR | 1.39e-05 | 1394 | 52 | 12 | M9585 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 1.68e-05 | 761 | 52 | 9 | M11961 | |
| Coexpression | GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 4.56e-05 | 198 | 52 | 5 | M5341 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 195 | 53 | 5 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.98e-06 | 200 | 53 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.98e-06 | 200 | 53 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 158 | 53 | 4 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.10e-05 | 171 | 53 | 4 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.10e-05 | 171 | 53 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-05 | 174 | 53 | 4 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.15e-05 | 193 | 53 | 4 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.65e-05 | 196 | 53 | 4 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.83e-05 | 197 | 53 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | severe-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | 61c7c08460856c188e62edf1fa62855578146fc8 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | severe-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | f74bdabadca8ad6dae1b6e6812c66325aac50db0 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.36e-05 | 200 | 53 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| Computational | Neighborhood of SMC1L1 | 3.20e-05 | 62 | 32 | 4 | MORF_SMC1L1 | |
| Computational | Neighborhood of TDG | 1.47e-04 | 35 | 32 | 3 | GNF2_TDG | |
| Computational | Neighborhood of ACP1 | 3.63e-04 | 211 | 32 | 5 | MORF_ACP1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.02e-04 | 49 | 32 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Neighborhood of XRCC5 | 5.95e-04 | 235 | 32 | 5 | MORF_XRCC5 | |
| Computational | Neighborhood of DEK | 6.62e-04 | 58 | 32 | 3 | GNF2_DEK | |
| Computational | Neighborhood of NPM1 | 1.24e-03 | 72 | 32 | 3 | GNF2_NPM1 | |
| Disease | Brachydactyly | 1.36e-05 | 4 | 45 | 2 | C0221357 | |
| Disease | Stevens-Johnson Syndrome | 9.63e-04 | 30 | 45 | 2 | C0038325 | |
| Disease | Global developmental delay | 1.11e-03 | 133 | 45 | 3 | C0557874 | |
| Disease | hyperuricemia | 1.17e-03 | 33 | 45 | 2 | EFO_0009104 | |
| Disease | Eczema | 1.27e-03 | 310 | 45 | 4 | HP_0000964 | |
| Disease | pulmonary function measurement, forced expiratory volume | 1.46e-03 | 37 | 45 | 2 | EFO_0003892, EFO_0004314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMEVDQPEPADTQPE | 981 | Q09472 | |
| VKKEDEPPEQAEPEP | 596 | P11171 | |
| QPPPPITEEDAQDMD | 71 | Q9UJX2 | |
| EPEEEEAVGMPKPLQ | 706 | Q8TER5 | |
| PDNSIKMPEEEDEAP | 461 | Q9UKL0 | |
| PSEPMEKDPAEPETV | 676 | Q9Y4C8 | |
| EEEEMPSKDPSPEPP | 701 | Q8IVL6 | |
| PPETPMEPDEQVTVE | 1276 | Q8WYB5 | |
| EMDPPNPEEVKTPEE | 96 | P0DTW1 | |
| VKPAEKRPDEEPMEE | 1066 | P56524 | |
| PEMQGTPDDEPSEPE | 186 | Q96GY3 | |
| EMDPPNPEEVKTPEE | 96 | O76087 | |
| KLPEPEELDLEPENM | 1286 | P08069 | |
| ADPVEEPDPEVMAKV | 326 | O43390 | |
| PVLPPMPEDIDDEED | 121 | Q5T2T1 | |
| EEEVPQPMPSIPEDL | 6 | Q9HBQ8 | |
| PDGQEMDPPNPEEVK | 91 | Q9UEU5 | |
| MDPPNPEEVKTPEEG | 96 | Q9UEU5 | |
| PDGQEMDPPNPEEVK | 91 | Q6NT46 | |
| MDPPNPEEVKTPEEG | 96 | Q6NT46 | |
| SDTPDEGDEPMPIPE | 21 | Q13422 | |
| VQPPPETPAEEEMET | 1076 | Q8IZL8 | |
| EDEGPAEEVPTQMPE | 456 | Q86Y91 | |
| KMAPPPKEVEEDSED | 16 | P19338 | |
| ESEETVEPKEDMPLP | 1206 | Q92794 | |
| EEAPQPMPSVPEDLE | 436 | D6RF30 | |
| EMDPPNPEEVKTPEE | 96 | A1L429 | |
| EMDPPNPEEVKTPEE | 96 | P0CL80 | |
| EMDPPNPEEVKTPEE | 96 | P0CL81 | |
| EMDPPNPEEVKTPEE | 96 | A6NDE8 | |
| EMDPPNPEEVKTPEE | 96 | P0CL82 | |
| EMDPPNPEEVKTPEE | 96 | A6NER3 | |
| KEPEMPGPREESEEE | 21 | P35659 | |
| MEEPVTIPDKPNSEE | 236 | P31415 | |
| IDKPDPPQGPMEVQD | 641 | Q86VF2 | |
| MVDPVPEEEKAGAEP | 1 | Q9NQR7 | |
| EMDPPNPEEVKTPEE | 96 | Q4V321 | |
| EEAPQPMPSVPEDPE | 436 | I6L899 | |
| EMDPPNPEEVKTPEE | 96 | Q13069 | |
| KIPLNMEEPPVEEPE | 256 | O60779 | |
| MEEPPVEEPEPKPDR | 261 | O60779 | |
| EEVAPQPPQPEEMEP | 886 | Q7Z6I6 | |
| DENMPDLPQDKPTPE | 421 | Q9HAU5 | |
| EPQPETEPEMEPNPK | 901 | Q96RN1 | |
| EMDPPNPEEVKTPEE | 96 | P0DSO3 | |
| AEEMETEPPHNEPIP | 46 | Q5JWF2 | |
| PDGQEMDPPNPEEVK | 91 | Q13066 | |
| MDPPNPEEVKTPEEG | 96 | Q13066 | |
| EPREPNLEPMVEKQE | 601 | Q9Y520 | |
| EEEDEKEPNSPVMVP | 231 | Q8TBK2 | |
| IPIPDPPPKDDEMET | 66 | Q9UL46 | |
| KDMDEPSPVPNVEEV | 341 | Q8TAQ2 | |
| LPPKPGTMEEEEEDD | 36 | Q6ZS10 | |
| DLPPKPGTMEEEEED | 61 | Q6ZS10 | |
| PEMEAEVEPEPNPEE | 31 | Q14028 | |
| DESEPPENPPPVLME | 236 | Q9Y242 | |
| MLEPTDEEPKEEKPP | 26 | Q96GT9 | |
| EEMEEENRIPQPPPI | 326 | Q5EBL4 | |
| SEEPLPMETEEEDPK | 481 | O14776 | |
| PMETEEEDPKEEPIK | 486 | O14776 | |
| PDEVPDDDEPAGPMK | 366 | Q9Y639 | |
| EPSEPLPEESKPVEM | 36 | Q99726 | |
| PPPTQTEEEEDPAMK | 1246 | Q07157 | |
| ESMEEQDEKPPEPPK | 26 | Q9UJW8 | |
| MPGETEEPRPPEQQD | 1 | Q96JP5 | |
| PQDKPFEEEETKEMP | 966 | Q8NAP3 | |
| MLEPGDEEPQQEEPP | 26 | Q8WTP9 |